Medtech's 2016 stock surge confronts second-quarter test

NEW YORK, July 8 (Reuters) - Shares of many U.S. companies that produce prescription medicines have been under pressure this year, but the picture has been rosier for makers of pacemakers, knee replacements and other medical devices.